Appello Pharmaceuticals Competitors and Similar CompaniesClear all
Appello Pharmaceuticals's competitors and similar companies include BioArctic, Bioasis Technologies, Genfit and Roche.
 Appello Pharmaceuticals Appello Pharmaceuticals is a preclinical-stage company that discovers and develops novel positive allosteric modulators for the treatment of Parkinson's disease. |  BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. |  Bioasis Technologies Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | ||
Founding Date | Founding Date N/A | Founding Date 2003 | Founding Date 2007 | Founding Date 1999 | Founding Date 1896 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Nashville, US HQ | Locations Stockholm , SE HQ | Locations New Haven, US HQ Burnaby, CA | Locations Loos, FR HQ Cambridge, US | |
Employees | Employees N/A | Employees 107 | Employees N/A | Employees 180 | Employees 103,249 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) 288.9 k | Valuation ($) 280.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods kr59.2m (FY, 2025) | Cost of goods N/A | Cost of goods €302k (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit kr1.9b (FY, 2025) | Gross profit N/A | Gross profit €70.8m (FY, 2025) | Gross profit CHF50.5b (FY, 2025) |
Net income | Net income N/A | Net income kr1b (FY, 2025) | Net income N/A | Net income (€86m) (FY, 2025) | Net income CHF13.8b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 10.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.8b |
For sources of this data, please see the company profile
View Company Profiles
BioArctic
HQ
Stockholm , SE
Employees
107
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View companyBioasis Technologies
HQ
New Haven, US
Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases.
View companyGenfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company